These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 29496075

  • 1. Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review.
    Jia Z, Wang W.
    Eur J Radiol; 2018 Mar; 100():23-29. PubMed ID: 29496075
    [Abstract] [Full Text] [Related]

  • 2. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases.
    King J, Quinn R, Glenn DM, Janssen J, Tong D, Liaw W, Morris DL.
    Cancer; 2008 Sep 01; 113(5):921-9. PubMed ID: 18618495
    [Abstract] [Full Text] [Related]

  • 3. A systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma.
    Jia Z, Jiang G, Zhu C, Wang K, Li S, Qin X.
    Eur J Radiol; 2017 Jul 01; 92():111-115. PubMed ID: 28624008
    [Abstract] [Full Text] [Related]

  • 4. Single-institution experience of radioembolization with yttrium-90 microspheres for unresectable metastatic neuroendocrine liver tumors.
    Jia Z, Paz-Fumagalli R, Frey G, Sella DM, McKinney JM, Wang W.
    J Gastroenterol Hepatol; 2017 Sep 01; 32(9):1617-1623. PubMed ID: 28132407
    [Abstract] [Full Text] [Related]

  • 5. Radioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.
    Paprottka PM, Hoffmann RT, Haug A, Sommer WH, Raessler F, Trumm CG, Schmidt GP, Ashoori N, Reiser MF, Jakobs TF.
    Cardiovasc Intervent Radiol; 2012 Apr 01; 35(2):334-42. PubMed ID: 21847708
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.
    Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB, Salem R.
    Int J Radiat Oncol Biol Phys; 2012 Jul 01; 83(3):887-94. PubMed ID: 22137020
    [Abstract] [Full Text] [Related]

  • 8. Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.
    Xing M, Prajapati HJ, Dhanasekaran R, Lawson DH, Kokabi N, Eaton BR, Kim HS.
    Am J Clin Oncol; 2017 Feb 01; 40(1):27-34. PubMed ID: 25089529
    [Abstract] [Full Text] [Related]

  • 9. Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases After Initial Peptide Receptor Radionuclide Therapy.
    Braat AJAT, Ahmadzadehfar H, Kappadath SC, Stothers CL, Frilling A, Deroose CM, Flamen P, Brown DB, Sze DY, Mahvash A, Lam MGEH.
    Cardiovasc Intervent Radiol; 2020 Feb 01; 43(2):246-253. PubMed ID: 31646375
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
    Egger ME, Armstrong E, Martin RC, Scoggins CR, Philips P, Shah M, Konda B, Dillhoff M, Pawlik TM, Cloyd JM.
    J Am Coll Surg; 2020 Apr 01; 230(4):363-370. PubMed ID: 32032719
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and laboratory toxicity after intra-arterial radioembolization with (90)y-microspheres for unresectable liver metastases.
    Smits ML, van den Hoven AF, Rosenbaum CE, Zonnenberg BA, Lam MG, Nijsen JF, Koopman M, van den Bosch MA.
    PLoS One; 2013 Apr 01; 8(7):e69448. PubMed ID: 23894481
    [Abstract] [Full Text] [Related]

  • 18. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients.
    Bester L, Meteling B, Pocock N, Pavlakis N, Chua TC, Saxena A, Morris DL.
    J Vasc Interv Radiol; 2012 Jan 01; 23(1):96-105. PubMed ID: 22079516
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience.
    Türk G, Eldem G, Kılıçkap S, Bozkurt FM, Salancı BV, Çil BE, Peynircioğlu B, Yalçın Ş, Balkancı F.
    J Gastrointest Cancer; 2019 Jun 01; 50(2):236-243. PubMed ID: 29354877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.